Yvonne Jauw

DRS.

20062019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 11 Article
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam

89Zr-immuno-PET: Towards a clinical tool to guide antibody-based therapy in cancer

Jauw, YWS., 19 Sep 2019

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

89 Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo

Jauw, Y., o'Donoghue, J., Zijlstra, J., Hoekstra, O., Menke-van der Houven van Oordt, C. W., Morschhauser, F., Carrasquillo, J., Zweegman, S., Pandit-Taskar, N., Lammertsma, A., van Dongen, G., Boellaard, R., Weber, W. & Huisman, M., 30 May 2019, In : Journal of Nuclear Medicine. p. jnumed.118.224568

Research output: Contribution to journalArticleAcademicpeer-review

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

Jauw, Y. W. S., Bensch, F., Brouwers, A. H., Hoekstra, O. S., Zijlstra, J. M., Pieplenbosch, S., Schröder, C. P., Zweegman, S., van Dongen, G. A. M. S., Menke-van der Houven van Oordt, C. W., de Vries, E. G. E., de Vet, H. C. W., Boellaard, R. & Huisman, M. C., 1 Aug 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, 9, p. 1840-1849

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody

Jauw, Y. W. S., Huisman, M. C., Nayak, T. K., Vugts, D. J., Christen, R., Naegelen, V. M., Ruettinger, D., Heil, F., Lammertsma, A. A., Verheul, H. M. W., Hoekstra, O. S., van Dongen, G. A. M. S. & van Oordt, C. W. M. D. H., 22 Jan 2018, In : EJNMMI Research. 8, 6.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access